ACHE and Alzheimer disease: According to these findings, the U.S. FDA has approved four AChE inhibitors: rivastigmine, tacrine, galantamine, and donepezil [15,16] for the treatment of dementia, delirium, traumatic brain injury, and AD (Figure 1).